Published in Biomaterials on August 07, 2010
Long distance directional growth of dopaminergic axons along pathways of netrin-1 and GDNF. Exp Neurol (2013) 1.40
A biomaterials approach to peripheral nerve regeneration: bridging the peripheral nerve gap and enhancing functional recovery. J R Soc Interface (2011) 1.32
Nanotechnology versus stem cell engineering: in vitro comparison of neurite inductive potentials. Int J Nanomedicine (2014) 0.84
c-Jun gene-modified Schwann cells: upregulating multiple neurotrophic factors and promoting neurite outgrowth. Tissue Eng Part A (2015) 0.83
Controlled dual delivery of fibroblast growth factor-2 and Interleukin-10 by heparin-based coacervate synergistically enhances ischemic heart repair. Biomaterials (2015) 0.80
Human umbilical cord blood-derived mesenchymal stem cells promote regeneration of crush-injured rat sciatic nerves. Neural Regen Res (2012) 0.76
Restoring nervous system structure and function using tissue engineered living scaffolds. Neural Regen Res (2015) 0.76
Electrospinning growth factor releasing microspheres into fibrous scaffolds. J Vis Exp (2014) 0.75
Invasive Intraneural Interfaces: Foreign Body Reaction Issues. Front Neurosci (2017) 0.75
Microencapsulation by solvent extraction/evaporation: reviewing the state of the art of microsphere preparation process technology. J Control Release (2005) 2.17
Preoperative transarterial embolization of vertebral metastases. Eur Spine J (2004) 1.30
Localized delivery of growth factors for bone repair. Eur J Pharm Biopharm (2004) 1.30
Nerve conduits and growth factor delivery in peripheral nerve repair. J Peripher Nerv Syst (2007) 1.29
TLR ligands and antigen need to be coencapsulated into the same biodegradable microsphere for the generation of potent cytotoxic T lymphocyte responses. Vaccine (2008) 1.26
Formulation aspects of biodegradable polymeric microspheres for antigen delivery. Adv Drug Deliv Rev (2005) 1.22
Administration routes affect the quality of immune responses: A cross-sectional evaluation of particulate antigen-delivery systems. J Control Release (2010) 1.20
Silk fibroin matrices for the controlled release of nerve growth factor (NGF). Biomaterials (2007) 1.17
Encapsulation of peptides in biodegradable microspheres prolongs their MHC class-I presentation by dendritic cells and macrophages in vitro. Vaccine (2003) 1.14
Localized insulin-like growth factor I delivery to enhance new bone formation. Bone (2003) 1.12
Particulate vaccines: on the quest for optimal delivery and immune response. Drug Discov Today (2011) 1.10
Schwann cell delivery of neurotrophic factors for peripheral nerve regeneration. J Peripher Nerv Syst (2010) 1.07
Synergistic effect of GDNF and NGF on axonal branching and elongation in vitro. Neurosci Res (2009) 1.05
Encapsulation of proteins and peptides into biodegradable poly(D,L-lactide-co-glycolide) microspheres prolongs and enhances antigen presentation by human dendritic cells. Vaccine (2005) 1.05
In vitro phagocytosis and monocyte-macrophage activation with poly(lactide) and poly(lactide-co-glycolide) microspheres. Eur J Pharm Sci (2002) 1.01
Growth factor delivery systems and repair strategies for damaged peripheral nerves. J Control Release (2011) 0.99
Collagen nerve conduits releasing the neurotrophic factors GDNF and NGF. J Control Release (2009) 0.98
Lympho-geographical concepts in vaccine delivery. J Control Release (2010) 0.97
Concomitant delivery of a CTL-restricted peptide antigen and CpG ODN by PLGA microparticles induces cellular immune response. J Drug Target (2009) 0.97
Gentamicin-loaded microspheres for treatment of experimental Brucella abortus infection in mice. J Antimicrob Chemother (2005) 0.92
Aesthetic Breast Augmentation Mastopexy Followed by Post-surgical Pyoderma Gangrenosum (PSPG): Clinic, Treatment, and Review of the Literature. Aesthetic Plast Surg (2015) 0.90
Biodegradable fibrin conduit promotes long-term regeneration after peripheral nerve injury in adult rats. J Plast Reconstr Aesthet Surg (2009) 0.90
Delivery of tumor antigens to dendritic cells using biodegradable microspheres. Methods Mol Med (2005) 0.89
Miconazole nanosuspensions: Influence of formulation variables on particle size reduction and physical stability. Int J Pharm (2010) 0.89
Phenotype and functional analysis of human monocyte-derived dendritic cells loaded with biodegradable poly(lactide-co-glycolide) microspheres for immunotherapy. J Immunol Methods (2004) 0.88
Gentamicin-loaded microspheres for reducing the intracellular Brucella abortus load in infected monocytes. J Antimicrob Chemother (2004) 0.88
Controlled nerve growth factor release from multi-ply alginate/chitosan-based nerve conduits. Eur J Pharm Biopharm (2008) 0.86
Surface coating of PLGA microparticles with protamine enhances their immunological performance through facilitated phagocytosis. J Control Release (2008) 0.86
Ultrasonic atomisation into reduced pressure atmosphere--envisaging aseptic spray-drying for microencapsulation. J Control Release (2004) 0.86
Instep free flap for plantar soft tissue reconstruction: indications and options. Microsurgery (2007) 0.85
Continuous contact- and contamination-free ultrasonic emulsification-a useful tool for pharmaceutical development and production. Ultrason Sonochem (2004) 0.85
The preservation of phenotype and functionality of dendritic cells upon phagocytosis of polyelectrolyte-coated PLGA microparticles. Biomaterials (2006) 0.85
One-step preparation of polyelectrolyte-coated PLGA microparticles and their functionalization with model ligands. J Control Release (2005) 0.85
Variations in glial cell line-derived neurotrophic factor release from biodegradable nerve conduits modify the rate of functional motor recovery after rat primary nerve repairs. Eur J Neurosci (2007) 0.84
In vivo uptake of an experimental microencapsulated diphtheria vaccine following sub-cutaneous immunisation. Vaccine (2004) 0.83
A protective allergy vaccine based on CpG- and protamine-containing PLGA microparticles. Pharm Res (2007) 0.82
Importance of single or blended polymer types for controlled in vitro release and plasma levels of a somatostatin analogue entrapped in PLA/PLGA microspheres. J Control Release (2004) 0.82
Biodegradable microspheres alone do not stimulate murine macrophages in vitro, but prolong antigen presentation by macrophages in vitro and stimulate a solid immune response in mice. J Control Release (2005) 0.82
Development of synthetic biodegradable microparticulate vaccines: a roller coaster story. Expert Rev Vaccines (2007) 0.81
Encapsulation of antigen in poly(D,L-lactide-co-glycolide) microspheres protects from harmful effects of γ-irradiation as assessed in mice. Eur J Pharm Biopharm (2011) 0.81
Insulin-like growth factor I-releasing alginate-tricalciumphosphate composites for bone regeneration. Pharm Res (2005) 0.81
The face lift SMAS plication flap for reconstruction of large temporofrontal defects: reconstructive surgery meets cosmetic surgery. Plast Reconstr Surg (2011) 0.80
On technological and immunological benefits of multivalent single-injection microsphere vaccines. Pharm Res (2002) 0.80
Hydrogel nerve conduits produced from alginate/chitosan complexes. J Biomed Mater Res A (2007) 0.80
An experimental divalent vaccine based on biodegradable microspheres induces protective immunity against tetanus and diphtheria. J Pharm Sci (2003) 0.80
Formulation and drying of miconazole and itraconazole nanosuspensions. Int J Pharm (2013) 0.79
Tumor eradication by immunotherapy with biodegradable PLGA microspheres--an alternative to incomplete Freund's adjuvant. Int J Cancer (2011) 0.79
Childhood and malaria vaccines combined in biodegradable microspheres produce immunity with synergistic interactions. J Control Release (2004) 0.78
Nerve conduit scaffolds for discrete delivery of two neurotrophic factors. Eur J Pharm Biopharm (2013) 0.77
Impact of IGF-I release kinetics on bone healing: a preliminary study in sheep. Eur J Pharm Biopharm (2013) 0.77
Effect of oil-in-water emulsions on 5-aminolevulinic acid uptake and metabolism to PpIX in cultured MCF-7 cells. Pharm Res (2004) 0.76
Gene expression profiling in nerve biopsy of vasculitic neuropathy. J Neuroimmunol (2010) 0.76
Polyelectrolyte LbL microcapsules versus PLGA microparticles for immunization with a protein antigen. J Control Release (2011) 0.76
Flow-through ultrasonic emulsification combined with static micromixing for aseptic production of microspheres by solvent extraction. Eur J Pharm Biopharm (2005) 0.76
Kinetics of solvent extraction/evaporation process for PLGA microparticle fabrication. Int J Pharm (2008) 0.76
[Scapholunate lesions and instabilities--how to recognize and treat them?]. Rev Med Suisse (2015) 0.75
Joint denervation and neuroma surgery as joint-preserving therapy for ankle pain. Foot Ankle Clin (2013) 0.75
Foreword - In honor of Prof. em. Dr. Hans Peter Merkle on the occasion of his 70th birthday. Eur J Pharm Biopharm (2013) 0.75
Development of a novel casein-protamine based microparticles for early feeding of fish larvae: in vitro evaluation. J Microencapsul (2007) 0.75
Preventing restenosis in early drug-eluting stent era: recent developments and future perspectives. J Pharm Pharmacol (2004) 0.75
Secret scar breast augmentation. J Plast Reconstr Aesthet Surg (2013) 0.75
Simultaneous quantification of polymeric and surface active stabilizers of nanosuspensions by using near-infrared spectroscopy. Drug Dev Ind Pharm (2012) 0.75
[Simple and complicated surgical wounds]. Ther Umsch (2012) 0.75